Table of Contents China Bioengineered Protein Drugs Market Report 2012-2023 1 Bioengineered Protein Drugs Overview 1.1 Product Overview and Scope of Bioengineered Protein Drugs 1.2 Classification of Bioengineered Protein Drugs by Product Category 1.2.1 China Bioengineered Protein Drugs Sales (K Units) Comparison by Types (2012-2023) 1.2.2 China Bioengineered Protein Drugs Sales (K Units) Market Share by Types in 2017 1.2.3 Therapeutic Proteins 1.2.4 Monoclonal Antibodies 1.2.5 Vaccines 1.3 China Bioengineered Protein Drugs Market by Application/End Users 1.3.1 China Bioengineered Protein Drugs (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 Diabetes and Hormonal Disorders 1.3.3 Genetic and Fertility Disorders 1.3.4 Cancers 1.3.5 Organ Transplants 1.3.6 Others 1.4 China Bioengineered Protein Drugs Market by Region 1.4.1 China Bioengineered Protein Drugs Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 South China Status and Prospect (2012-2023) 1.4.3 East China Status and Prospect (2012-2023) 1.4.4 Southwest China Status and Prospect (2012-2023) 1.4.5 Northeast China Status and Prospect (2012-2023) 1.4.6 North China Status and Prospect (2012-2023) 1.4.7 Central China Status and Prospect (2012-2023) 1.4.8 Northwest China Status and Prospect (2012-2023) 1.5 China Sales and Revenue ofSales and Revenue of Bioengineered Protein Drugs (2012-2023) 1.5.1 China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2023) 1.5.2 China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Bioengineered Protein Drugs 2.2 Raw Material Analysis of Bioengineered Protein Drugs 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Bioengineered Protein Drugs 2.4 Other Costs Analysis of Bioengineered Protein Drugs 2.5 Manufacturing Cost Structure Analysis of Bioengineered Protein Drugs 2.6 Manufacturing Process Analysis of Bioengineered Protein Drugs 2.7 Raw Materials Sources of Bioengineered Protein Drugs Major Manufacturers in 2018 2.8 Downstream Buyers 3 China Bioengineered Protein Drugs Players/Suppliers Profiles and Sales Data 3.1 Abbott Laboratories 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Abbott Laboratories Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Abbott Laboratories Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Abbott Laboratories Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.2 F. Hoffmann-La Roche Ltd 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 F. Hoffmann-La Roche Ltd Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.3 Amgen, Inc. 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 Amgen, Inc. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Amgen, Inc. Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 Amgen, Inc. Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.4 Bayer AG 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Bayer AG Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Bayer AG Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Bayer AG Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.5 Merck & Co., Inc. 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Merck & Co., Inc. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Merck & Co., Inc. Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 Merck & Co., Inc. Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.6 Dr. Reddy's Laboratories Ltd. 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Dr. Reddy's Laboratories Ltd. Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.7 Biocon Ltd. 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Biocon Ltd. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Biocon Ltd. Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Biocon Ltd. Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.8 Eli Lilly and Company 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 Eli Lilly and Company Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Eli Lilly and Company Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 Eli Lilly and Company Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.9 Sanofi 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 Sanofi Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Sanofi Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.9.5 Sanofi Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.10 GlaxoSmithKline plc 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 GlaxoSmithKline plc Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 GlaxoSmithKline plc Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.10.5 GlaxoSmithKline plc Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.11 Johnson & Johnson 3.12 JanssenNovartis AG 3.13 Panacea Biotec 3.14 ProBioGen AG 4 China Bioengineered Protein Drugs Competition by Players/Manufacturers, Region, Type and Application 4.1 China Bioengineered Protein Drugs Market Competition by Players/Manufacturers 4.1.1 China Bioengineered Protein Drugs Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 China Bioengineered Protein Drugs Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 China Bioengineered Protein Drugs Sales and Revenue by Type 4.2.1 China Bioengineered Protein Drugs Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 China Bioengineered Protein Drugs Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 China Bioengineered Protein Drugs Sales and Revenue by Application 4.3.1 China Bioengineered Protein Drugs Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 China Bioengineered Protein Drugs Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 China Bioengineered Protein Drugs Sales (K Units) by Application 5 South China Bioengineered Protein Drugs (Sales, Revenue and Price) 5.1 South China Bioengineered Protein Drugs Sales and Value (2012-2017) 5.1.1 South China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) 5.1.2 South China Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 5.1.3 South China Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) 5.2 South China Bioengineered Protein Drugs Sales (K Units) and Market Share by Type 5.3 South China Bioengineered Protein Drugs Sales (K Units) and Market Share by Application 6 East China Bioengineered Protein Drugs (Sales, Revenue and Price) 6.1 East China Bioengineered Protein Drugs Sales and Value (2012-2017) 6.1.1 East China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) 6.1.2 East China Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 6.1.3 East China Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) 6.2 East China Bioengineered Protein Drugs Sales (K Units) and Market Share by Type 6.3 East China Bioengineered Protein Drugs Sales (K Units) and Market Share by Application 7 Southwest China Bioengineered Protein Drugs (Sales, Revenue and Price) 7.1 Southwest China Bioengineered Protein Drugs Sales and Value (2012-2017) 7.1.1 Southwest China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) 7.1.2 Southwest China Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 7.1.3 Southwest China Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) 7.2 Southwest China Bioengineered Protein Drugs Sales (K Units) and Market Share by Type 7.3 Southwest China Bioengineered Protein Drugs Sales (K Units) and Market Share by Application 8 Northeast China Bioengineered Protein Drugs (Sales, Revenue and Price) 8.1 Northeast China Bioengineered Protein Drugs Sales and Value (2012-2017) 8.1.1 Northeast China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) 8.1.2 Northeast China Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 8.1.3 Northeast China Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) 8.2 Northeast China Bioengineered Protein Drugs Sales (K Units) and Market Share by Type 8.3 Northeast China Bioengineered Protein Drugs Sales (K Units) and Market Share by Application 9 North China Bioengineered Protein Drugs (Sales, Revenue and Price) 9.1 North China Bioengineered Protein Drugs Sales and Value (2012-2017) 9.1.1 North China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) 9.1.2 North China Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 9.1.3 North China Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) 9.2 North China Bioengineered Protein Drugs Sales (K Units) and Market Share by Type 9.3 North China Bioengineered Protein Drugs Sales (K Units) and Market Share by Application 10 Central China Bioengineered Protein Drugs (Sales, Revenue and Price) 10.1 Central China Bioengineered Protein Drugs Sales and Value (2012-2017) 10.1.1 Central China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) 10.1.2 Central China Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 10.1.3 Central China Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) 10.2 Central China Bioengineered Protein Drugs Sales (K Units) and Market Share by Type 10.3 Central China Bioengineered Protein Drugs Sales (K Units) and Market Share by Application 11 Northwest China Bioengineered Protein Drugs (Sales, Revenue and Price) 11.1 Northwest China Bioengineered Protein Drugs Sales and Value (2012-2017) 11.1.1 Northwest China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) 11.1.2 Northwest China Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 11.1.3 Northwest China Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) 11.2 Northwest China Bioengineered Protein Drugs Sales (K Units) and Market Share by Type 11.3 Northwest China Bioengineered Protein Drugs Sales (K Units) and Market Share by Application 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Direct Marketing 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List 13 China Bioengineered Protein Drugs Market Forecast (2018-2023) 13.1 China Bioengineered Protein Drugs Sales (K Units), Revenue and Price Forecast (2018-2023) 13.1.1 China Bioengineered Protein Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) 13.1.2 China Bioengineered Protein Drugs Revenue and Growth Rate Forecast (2018-2023) 13.1.3 China Bioengineered Protein Drugs Price and Trend Forecast (2018-2023) 13.2 China Bioengineered Protein Drugs Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 China Bioengineered Protein Drugs Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 13.2.2 China Bioengineered Protein Drugs Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.3 South China Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 East China Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 Southwest China Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Northeast China Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 Southwest China Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Central China Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.9 Northwest China Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.3 China Bioengineered Protein Drugs Sales, Revenue and Price Forecast by Type (2018-2023) 13.3.1 China Bioengineered Protein Drugs Sales Forecast by Type (2018-2023) 13.3.2 China Bioengineered Protein Drugs Revenue Forecast by Type (2018-2023) 13.3.3 China Bioengineered Protein Drugs Price Forecast by Type (2018-2023) 13.4 China Bioengineered Protein Drugs Sales Forecast by Application (2018-2023) 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology/Research Approach 15.1.1 Research Programs/Design 15.1.2 Market Size Estimation 15.1.3 Market Breakdown and Data Triangulation 15.2 Data Source 15.2.1 Secondary Sources 15.2.2 Primary Sources 15.3 Disclaimer

List of Tables and Figures Figure China Market Size (Million USD) Comparison 2012-2023 Table China Market Bioengineered Protein Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Table China Bioengineered Protein Drugs Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table China Bioengineered Protein Drugs Sales (K Units) by Application (2016-2023) Figure Product Picture of Bioengineered Protein Drugs Table China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure China Bioengineered Protein Drugs Sales (K Units) Market Share by Types in 2017 Figure Therapeutic Proteins Picture Figure Monoclonal Antibodies Picture Figure Vaccines Picture Table China Bioengineered Protein Drugs Sales (K Units) Comparison by Applications (2012-2023) Figure China Sales Market Share of Bioengineered Protein Drugs by Applications in 2017 Figure Diabetes and Hormonal Disorders Picture Figure Genetic and Fertility Disorders Picture Figure Cancers Picture Table China Market Bioengineered Protein Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Figure South China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure East China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Southwest China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Northeast China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure North China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Central China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Northwest China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2023) Figure China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Bioengineered Protein Drugs Table Industry News List of Bioengineered Protein Drugs Figure Industry Chain Structure of Bioengineered Protein Drugs Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Bioengineered Protein Drugs in 2017 Figure Manufacturing Process Analysis of Bioengineered Protein Drugs Table Raw Materials Sources of Bioengineered Protein Drugs Major Manufacturers China Table Major Buyers of Bioengineered Protein Drugs Table Abbott Laboratories Basic Information List Table Abbott Laboratories Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Abbott Laboratories Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Abbott Laboratories Bioengineered Protein Drugs Sales China Market Share (%) (2012-2017) Figure Abbott Laboratories Bioengineered Protein Drugs Revenue China Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Abbott Laboratories Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Abbott Laboratories Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Abbott Laboratories Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table F. Hoffmann-La Roche Ltd Basic Information List Table F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales China Market Share (%) (2012-2017) Figure F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Revenue China Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Amgen, Inc. Basic Information List Table Amgen, Inc. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Amgen, Inc. Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Amgen, Inc. Bioengineered Protein Drugs Sales China Market Share (%) (2012-2017) Figure Amgen, Inc. Bioengineered Protein Drugs Revenue China Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Amgen, Inc. Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Amgen, Inc. Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Amgen, Inc. Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Bayer AG Basic Information List Table Bayer AG Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Bayer AG Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Bayer AG Bioengineered Protein Drugs Sales China Market Share (%) (2012-2017) Figure Bayer AG Bioengineered Protein Drugs Revenue China Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Bayer AG Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Bayer AG Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Bayer AG Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Merck & Co., Inc. Basic Information List Table Merck & Co., Inc. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Merck & Co., Inc. Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Merck & Co., Inc. Bioengineered Protein Drugs Sales China Market Share (%) (2012-2017) Figure Merck & Co., Inc. Bioengineered Protein Drugs Revenue China Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Merck & Co., Inc. Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Merck & Co., Inc. Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Merck & Co., Inc. Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Dr. Reddy's Laboratories Ltd. Basic Information List Table Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Sales China Market Share (%) (2012-2017) Figure Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Revenue China Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Biocon Ltd. Basic Information List Table Biocon Ltd. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Biocon Ltd. Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Biocon Ltd. Bioengineered Protein Drugs Sales China Market Share (%) (2012-2017) Figure Biocon Ltd. Bioengineered Protein Drugs Revenue China Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Biocon Ltd. Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Biocon Ltd. Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Biocon Ltd. Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Eli Lilly and Company Basic Information List Table Eli Lilly and Company Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Eli Lilly and Company Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Eli Lilly and Company Bioengineered Protein Drugs Sales China Market Share (%) (2012-2017) Figure Eli Lilly and Company Bioengineered Protein Drugs Revenue China Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Eli Lilly and Company Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Eli Lilly and Company Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Eli Lilly and Company Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Sanofi Basic Information List Table Sanofi Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sanofi Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Sanofi Bioengineered Protein Drugs Sales China Market Share (%) (2012-2017) Figure Sanofi Bioengineered Protein Drugs Revenue China Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sanofi Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Sanofi Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Sanofi Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Company GlaxoSmithKline plc Basic Information List Table Company GlaxoSmithKline plc Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company GlaxoSmithKline plc Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Company GlaxoSmithKline plc Bioengineered Protein Drugs Sales China Market Share (%) (2012-2017) Figure Company GlaxoSmithKline plc Bioengineered Protein Drugs Revenue China Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Company GlaxoSmithKline plc Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Company GlaxoSmithKline plc Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Company GlaxoSmithKline plc Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table China Bioengineered Protein Drugs Sales (K Units) by Players/Manufacturers (2012-2017) Table China Bioengineered Protein Drugs Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 China Bioengineered Protein Drugs Sales Market Share (%) by Players/Manufacturers Figure 2017 China Bioengineered Protein Drugs Sales Share by Players/Manufacturers Table China Bioengineered Protein Drugs Revenue (Million USD) by Players/Manufacturers (2012-2017) Table China Bioengineered Protein Drugs Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 China Bioengineered Protein Drugs Revenue Market Share (%) Players Figure 2017 China Bioengineered Protein Drugs Revenue Market Share (%) Players Table China Bioengineered Protein Drugs Sales (K Units) and Market Share (%) by Type (2012-2017) Table China Bioengineered Protein Drugs Sales Share by Type (2012-2017) Figure Sales Market Share of Bioengineered Protein Drugs by Type (2012-2017) Figure China Bioengineered Protein Drugs Sales Growth Rate (%) by Type (2012-2017) Table China Bioengineered Protein Drugs Revenue (Million USD) and Market Share (%) Type (2012-2017) Table China Bioengineered Protein Drugs Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Bioengineered Protein Drugs by Type (2012-2017) Figure China Bioengineered Protein Drugs Revenue Growth Rate by Type (2012-2017) Table China Bioengineered Protein Drugs Sales (K Units) and Market Share by Regions (2012-2017) Table China Bioengineered Protein Drugs Sales Share by Regions (2012-2017) Figure Sales Market Share of Bioengineered Protein Drugs by Regions (2012-2017) Figure China Bioengineered Protein Drugs Sales Market Share by Regions in 2017 Table China Bioengineered Protein Drugs Revenue (Million USD) and Market Share by Regions (2012-2017) Table China Bioengineered Protein Drugs Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Bioengineered Protein Drugs by Regions (2012-2017) Figure China Bioengineered Protein Drugs Revenue Market Share by Regions in 2017 Table China Bioengineered Protein Drugs Sales (K Units) and Market Share by Application (2012-2017) Table China Bioengineered Protein Drugs Sales Share (%) by Application (2012-2017) Figure China Bioengineered Protein Drugs Sales Market Share by Application (2012-2017) Figure China Bioengineered Protein Drugs Sales Market Share by Application (2012-2017) Figure South China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) (2012-2017) Figure South China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure South China Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) Table South China Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table South China Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017) Figure South China Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017 Table South China Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table South China Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure South China Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017 Figure East China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) Figure East China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure East China Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) Table East China Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table East China Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017) Figure East China Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017 Table East China Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table East China Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure East China Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017 Figure Southwest China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Southwest China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Southwest China Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Southwest China Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table Southwest China Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Southwest China Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017 Table Southwest China Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table Southwest China Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Southwest China Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017 Figure Northeast China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Northeast China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Northeast China Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Northeast China Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table Northeast China Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Northeast China Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017 Table Northeast China Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table Northeast China Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Northeast China Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017 Figure Central China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Central China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Central China Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Central China Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table Central China Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Central China Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017 Table Central China Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table Central China Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Central China Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017 Figure North China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) Figure North China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure North China Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) Table North China Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table North China Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017) Figure North China Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017 Table North China Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table North China Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure North China Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017 Figure Northwest China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Northwest China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Northwest China Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Northwest China Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table Northwest China Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Northwest China Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017 Table Northwest China Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table Northwest China Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Northwest China Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure China Bioengineered Protein Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) Figure China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure China Bioengineered Protein Drugs Price and Trend Forecast (2018-2023) Table China Bioengineered Protein Drugs Sales (K Units) Forecast by Regions (2018-2023) Figure China Bioengineered Protein Drugs Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure China Bioengineered Protein Drugs Sales (K Units) Market Share Forecast by Regions in 2023 Table China Bioengineered Protein Drugs Revenue (Million USD) Forecast by Regions (2018-2023) Figure China Bioengineered Protein Drugs Revenue Market Share Forecast by Regions (2018-2023) Figure China Bioengineered Protein Drugs Revenue Market Share Forecast by Regions in 2023 Figure South China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure South China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Southwest China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Southwest China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure East China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure East China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Northeast China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Northeast China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure North China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure North China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Central China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Central China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Northwest China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Northwest China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table China Bioengineered Protein Drugs Sales (K Units) Forecast by Type (2018-2023) Figure China Bioengineered Protein Drugs Sales Market Share Forecast by Type (2018-2023) Table China Bioengineered Protein Drugs Revenue (Million USD) Forecast by Type (2018-2023) Figure China Bioengineered Protein Drugs Revenue Market Share Forecast by Type (2018-2023) Table China Bioengineered Protein Drugs Price (USD/Unit) Forecast by Type (2018-2023) Table China Bioengineered Protein Drugs Sales (K Units) Forecast by Application (2018-2023) Figure China Bioengineered Protein Drugs Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Abbott Laboratories F. Hoffmann-La Roche Ltd Amgen, Inc. Bayer AG Merck & Co., Inc. Dr. Reddy's Laboratories Ltd. Biocon Ltd. Eli Lilly and Company Sanofi GlaxoSmithKline plc Johnson & Johnson JanssenNovartis AG Panacea Biotec ProBioGen AG